These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
908 related articles for article (PubMed ID: 12520635)
1. Current status of capecitabine in the treatment of colorectal cancer. Rothenberg ML Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):16-22. PubMed ID: 12520635 [TBL] [Abstract][Full Text] [Related]
2. Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer? Twelves C Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):23-6. PubMed ID: 12520636 [TBL] [Abstract][Full Text] [Related]
3. Capecitabine: a review. Walko CM; Lindley C Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604 [TBL] [Abstract][Full Text] [Related]
5. Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced gastrointestinal cancers. Jordan K; Kellner O; Kegel T; Schmoll HJ; Grothey A Clin Colorectal Cancer; 2004 May; 4(1):46-50. PubMed ID: 15207020 [TBL] [Abstract][Full Text] [Related]
6. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer. Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L Oncology; 2004; 66(5):371-8. PubMed ID: 15331924 [TBL] [Abstract][Full Text] [Related]
8. Oral capecitabine: bridging the Atlantic divide in colon cancer treatment. Van Cutsem E; Verslype C; Tejpar S Semin Oncol; 2005 Feb; 32(1):43-51. PubMed ID: 15726505 [TBL] [Abstract][Full Text] [Related]
9. Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer. Moosmann N; Heinemann V Clin Colorectal Cancer; 2008 Mar; 7(2):110-7. PubMed ID: 18501070 [TBL] [Abstract][Full Text] [Related]
10. Capecitabine/irinotecan in colorectal cancer: European early-phase data and planned trials. Kerr D Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):12-5. PubMed ID: 12520634 [TBL] [Abstract][Full Text] [Related]
11. [Recent results of irinotecan therapy in colorectal cancer]. Láng I; Hitre E Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572 [TBL] [Abstract][Full Text] [Related]
12. A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer. Choi DR; Yoon SN; Kim HS; Kim JH; Kim KY; Kim BC; Choi YK; Kim JB; Han B; Song HH; Zang DY Cancer Chemother Pharmacol; 2015 Mar; 75(3):639-43. PubMed ID: 25630415 [TBL] [Abstract][Full Text] [Related]
13. The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer. Shin SJ; Ahn JB; Choi HJ; Cho BC; Jeung HC; Rha SY; Chung HC; Roh JK Cancer Chemother Pharmacol; 2008 Jan; 61(1):75-81. PubMed ID: 17375304 [TBL] [Abstract][Full Text] [Related]
14. Dosing considerations for capecitabine-irinotecan regimens in the treatment of metastatic and/or locally advanced colorectal cancer. Cartwright T; McCollum D; Boehm KA Am J Clin Oncol; 2010 Jun; 33(3):307-13. PubMed ID: 20375835 [TBL] [Abstract][Full Text] [Related]
15. Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741. Delaunoit T; Goldberg RM; Sargent DJ; Morton RF; Fuchs CS; Findlay BP; Thomas SP; Salim M; Schaefer PL; Stella PJ; Green E; Mailliard JA Cancer; 2004 Nov; 101(10):2170-6. PubMed ID: 15470715 [TBL] [Abstract][Full Text] [Related]
16. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting. Folprecht G; Köhne CH Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098 [TBL] [Abstract][Full Text] [Related]
17. Treatment of colorectal cancer metastasis: the role of chemotherapy. Xiong HQ; Ajani JA Cancer Metastasis Rev; 2004; 23(1-2):145-63. PubMed ID: 15000155 [TBL] [Abstract][Full Text] [Related]
18. Differences in efficacy and safety between capecitabine and infusional 5-fluorouracil when combined with irinotecan for the treatment of metastatic colorectal cancer. Montagnani F; Chiriatti A; Licitra S; Aliberti C; Fiorentini G Clin Colorectal Cancer; 2010 Oct; 9(4):243-7. PubMed ID: 20920997 [TBL] [Abstract][Full Text] [Related]
19. Irinotecan, oxaliplatin plus bolus 5-fluorouracil and low dose folinic acid every 2 weeks: a feasibility study in metastatic colorectal cancer patients. Martinez J; Martin C; Chacon M; Korbenfeld E; Bella S; Senna S; Richardet E; Coppola F; Bas C; Hidalgo J; Escobar E; Reale M; Smilovich AM; Wasserman E Am J Clin Oncol; 2006 Feb; 29(1):45-51. PubMed ID: 16462502 [TBL] [Abstract][Full Text] [Related]
20. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. Van Cutsem E; Twelves C; Cassidy J; Allman D; Bajetta E; Boyer M; Bugat R; Findlay M; Frings S; Jahn M; McKendrick J; Osterwalder B; Perez-Manga G; Rosso R; Rougier P; Schmiegel WH; Seitz JF; Thompson P; Vieitez JM; Weitzel C; Harper P; J Clin Oncol; 2001 Nov; 19(21):4097-106. PubMed ID: 11689577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]